The bronchodilator test in chronic obstructive pulmonary disease: interpretation methods
Heredia, J. L.
MetadataShow full item record
The objective of the study was to evaluate the best method for interpreting the bronchodilator test (BDT). Five formulas for expressing the BDT results were analyzed and compared: changes experienced by maximum expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) measured in milliliters,
in percentage with respect to the baseline, in percentage with respect to the predicted, in percentage with respect to the possible, and in standardized residuals. Ninety-eight chronic obstructive pulmonary disease (COPD) patients were submitted to a respiratory function test on two different days. On each occasion three spirometries were conducted: basal, post-placebo and post bronchodilator. As a gold standard, a normality interval was defined using the variability experienced with the placebo between the two days of the study. The best formulas according to their sensitivity, specivity and area under receiver operating characteristic (ROC) curve were the ‘‘standardized residuals’’, with a cut point of .3, and the ‘‘percentage with respect to the predicted’’ with a cut point of 6%.
Is part ofRespiratory Medicine, 2007, vol. 101, núm. 1, p. 34-42
European research projects
Showing items related by title, author, creator and subject.
The Bronchodilator Test with Increasing Doses of Terbutaline in Chronic Obstructive Pulmonary Disease Patients Rodríguez-Carballeira, M.; Heredia, J. L.; Rué i Monné, Montserrat; Quintana, Salvador; Gómez, S. (Elsevier, 2001)There is no uniform consensus on the dose of bronchodilator to be used in the bronchodilator test (BDT). The objective of the study was to determine the dose of inhaled terbutaline that can safely achieve a greater number ...
Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study Montserrat i Capdevila, Josep; Godoy i García, Pere; Marsal Mora, Josep Ramon; Barbé Illa, Ferran; Galván, Leonardo (BioMed Central, 2015)Background: The risk of exacerbation in chronic obstructive pulmonary disease (COPD) depends on the severity of disease and other less well known factors. Predictive models of exacerbation are more accurate than the forced ...
C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease Ruiz González, Agustín; Lacasta García, José Daniel; Ibarz Escuer, Mercedes; Martínez Alonso, Montserrat; Falguera i Sacrest, Miquel; Porcel Pérez, José Manuel (Wiley, 2008)Background and objective: CRP is elevated in patients with acute exacerbations of COPD (AECOPD), but there is little information on whether this biomarker can help to identify adverse short-term clinical outcomes. Methods: ...